Mice that were given olive oil 15 minutes before a dose of glucose showed a smaller early rise in blood sugar and slower emptying of the stomach than mice given the same oil afterward. The effect also appeared in mice with type 2 diabetes. No human has been tested, and the researchers say human studies are still needed.
The experiment: three orders, one meal
The design was simple. After fasting overnight, mice were split into three groups: water followed by glucose, olive oil followed by glucose 15 minutes later, and glucose followed by olive oil 15 minutes later. Because the groups received the same ingredients in different sequences, any difference in blood sugar could be pinned to timing rather than to the oil itself, which is the whole point of the comparison.
The result comes from a Kyoto University study released on 8 October 2026, which reported a smaller early glucose rise and slower gastric emptying when the oil came first. The team tracked blood glucose alongside insulin, glucagon, GIP and GLP-1, hormones released by the gut and pancreas. Gastric emptying was estimated by giving acetaminophen by mouth and measuring how quickly it appeared in the blood, a standard indirect readout of how fast the stomach hands its contents to the intestine. Further groups included mice with type 2 diabetes and severe insulin deficiency, mice lacking the GLP-1 receptor, and animals fed other dietary fats for comparison, as the EurekAlert version of the release lists.
Glucagon, GLP-1 and the vagus nerve as the proposed route
Oil first produced a smaller initial glucose rise than oil afterward, and it slowed gastric emptying, which delays the moment glucose reaches the intestine where it is absorbed. It also triggered an early increase in glucagon, GIP and GLP-1. Daisuke Yabe of Kyoto University, the corresponding author, said the order in which nutrients reach the gut can engage a coordinated hormone-nerve response.
The surprising part is how the pieces fit. Blocking glucagon signaling alone did not remove the benefit, and neither did blocking GLP-1 signaling alone. Blocking both reduced it. The paper’s own title calls the pathways “partially redundant,” meaning the body appears to have two overlapping routes to the same slowdown, so shutting one leaves the other working. Cutting the vagus nerves below the diaphragm in a further set of animals suggested that nerve signaling from the gut contributes as well.
Missing dose and group-size details in the public summaries
The accessible descriptions of the work leave out several details a careful reader would want. They do not name the mouse strain, state how many animals were in each group, give the amount of olive oil or glucose, report the size of the glucose reduction, or name the statistical tests behind the comparisons. The release uses the phrase “dramatically reduced” without a figure attached. Those numbers sit in the full paper, published in Diabetes under DOI 10.2337/db26-0531, and the journal’s article page carries the full wording, “Olive Oil Before Oral Glucose Delays Gastric Emptying and Lowers Glycemia Through Partially Redundant Glucagon and GLP-1 Signaling in Mice.”
Dose is the sharpest unanswered question. Mouse experiments usually give a fixed volume scaled to body weight, and a mouse weighs a tiny fraction of an adult human, so a dose that is meaningful in a mouse does not translate into a spoonful by simple multiplication. Nothing in the release says how the dose was chosen or whether it maps to any amount a person might eat.
What a human trial would have to show
Yabe framed the appeal of the idea in practical terms, saying that meal-sequencing is appealing because it merely changes how a meal is eaten. That is a reason the question is worth testing, not evidence that it works in people. Coverage by Medical Xpress and News-Medical repeats the same mouse-only framing.
A human trial would need to start with the same crossover logic as the mouse work: the same participants eating the same meal with and without a fat pre-load, in randomized order, with glucose, insulin, GLP-1 and gastric emptying measured at the same intervals. It would need to include people with type 2 diabetes, since that group is the motivation, and to test realistic portions of ordinary food rather than a glucose solution given by tube. It would also have to ask whether the effect holds across a full day of meals, whether any benefit survives the extra calories from the oil, and whether it matters over months for measures such as long-term average blood sugar.
Until that evidence exists, the finding stands as a mechanism in mice: a fat eaten first can engage overlapping gut hormones and nerves that slow the stomach and soften the early glucose peak, with glucagon and GLP-1 each able to cover for the other. Whether the same chain operates in human physiology, at what dose, and with what size of benefit, is exactly what the authors say remains to be shown.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- Lake Powell sank to a record 3,517 feet, nearing the level that stops Glen Canyon Dam’s turbines
- Seven of Earth’s nine planetary boundaries are breached, and all seven are worsening
- The NSA says three phone features should be off whenever you aren’t using them
- Hurricane Hunter radar shows four warning signs that a tropical cyclone is about to strengthen, a University of Miami study found
